Neurology

Nilotinib Is Safe in Moderate and Advanced Parkinson's Disease



Although nilotinib is safe and tolerable in patients with moderate or advanced Parkinson’s disease, it may not affect the disease’s symptoms, according to investigators.
Medscape Medical News

Source link

Related posts

World’s largest sleep study shows too much shut-eye can be bad for your brain

Newsemia

Age and time course of long-term motor and nonmotor complications in Parkinson disease

Newsemia

Commentary: Neurosurgical Coverage for Emergency and Trauma Call.

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World